ArticleBMC cancer2026

Patient preference for first-line treatments of ALK-positive metastatic non-small cell lung cancer: a discrete choice experiment.

Jiachen Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.